A working coronavirus vaccine finally looks in sight. Following an announcement from Pfizer/BioNTech which showed their large-scale trials of the vaccine was 90% effective.
The high percentage of effectiveness is even more compelling given regulators said they would approve a vaccine if it were just 50% effective. 90% effectiveness puts it beyond expectations and gives the world a strong glimmer of hope in its fight against coronavirus.
The company also said there were no serious side-effects detected with the vaccine.
Dr Albert Bourla, Pfizer chairman and CEO said:
Today is a great day for science and humanity. The first set of results from our phase 3 Covid-19 vaccine trial provides the initial evidence of our vaccine’s ability to prevent Covid-19.
We are reaching this critical milestone in our vaccine development program at a time when the world needs it most with infection rates setting new records, hospitals nearing over-capacity and economies struggling to reopen
The phase 3 trials of the vaccine have involved more than 43,000 people. The findings of the trials will no doubt excite public health officials and politicians alike and puts a potential end of the Covid-19 pandemic on the horizon.
Pfizer has plans to manufacture 100 million of these vaccines this year and 1.3 billion by the end 2021.
This news follows Pfzier’s announcement last week that they are investing a further 300m in its Irish operations, creating 300 new jobs in the process.
Recruit Island is Ireland’s fastest growing jobs boards and showcases 1000’s of job vacancies across Ireland. Find a job today!